Predicting Colorectal Cancer Recurrence
Liquid biopsy tests can find tiny amounts of disease that remain after surgery and chemotherapy.
Progress Against Cancer
Liquid biopsy tests can find tiny amounts of disease that remain after surgery and chemotherapy.
KRAS mutations were once thought to be resistant to drug therapy.
An immunotherapy combination continues to be effective in treating kidney cancer patients, and more news of the week from Cancer Today.
9/11 first responders’ cancer survival compares favorably to the general population, and more news of the week from Cancer Today.
Cancer is often described as a disease of old age, but over 15,000 children are diagnosed with cancer each year in the United States. While pediatric cancers tend to have higher survival rates than...
What if a machine could “think” like a doctor and diagnose and treat a disease? This is one of the long-term goals for the field of artificial intelligence (AI). In a session co-sponsored by the American Association for Cancer Research...
Regular exercise can help mitigate cognitive problems associated with chemotherapy, and more news of the week from Cancer Today.
Glioblastoma is an aggressive form of brain cancer. Less than 5 percent of patients diagnosed with this cancer type will survive for five years or more. Glioblastoma is notoriously difficult to treat, and new avenues...
Patient volume at radiation therapy clinics can affect outcomes, and more news of the week from Cancer Today.
Survival is not affected by delaying breast cancer treatment for fertility preservation, and more news of the week from Cancer Today.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More